CDH1 and glomerulosclerosis: Podocyte‐specific deletion of Btg2 protected against the onset of proteinuria and glomerulosclerosis in ADR‐treated mice along with inhibition of EMT markers such as α‐SMA and vimentin while restoring epithelial marker E‐cadherin.